Detection and persistence of Zika virus in body fluids and associated factors: a prospective cohort study
Guilherme Amaral Calvet, Kayvon Modjarrad(Pfizer (United States)), Camila Bôtto-Menezes(Fundação de Medicina Tropical), Márcia da Costa Castilho(Fundação de Medicina Tropical), Ximena Pamela Díaz Bermúdez(Universidade de Brasília), Gérson Fernando Mendes Pereira(Ministério da Saúde), Edna Kara(World Health Organization), Nathalie Broutet(World Health Organization), Rafael Freitas de Oliveira França(Fundação Oswaldo Cruz), Ndema Habib(World Health Organization), Silvana Pereira Giozza(Ministério da Saúde), Tatiana Jorge Fernandes(Fundação Oswaldo Cruz), Armando Menezes‐Neto(Fundação Oswaldo Cruz), Patrícia Brasil(Instituto Evandro Chagas), Ana María Bispo de Filippis(Fundação Oswaldo Cruz)
Cited by 23
Related Papers
Estimates of the global burden of cervical cancer associated with HIV
|The Lancet Global Health|2020|912
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
|Scientific Reports|2017|243
Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol
|SpringerPlus|2015|206
Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum
|Science Translational Medicine|2017|197